CClinicalTrials.gg
TerminatedNCT02441959Updated Aug 7, 2018

Full-Endoscopic vs Open Discectomy for the Treatment of Symptomatic Lumbar Herniated Disc

An interventional study of Lumbar discectomy Open and Lumbar discectomy Endoscopic in Lumbar Disc Herniation, sponsored by Yale University. Terminated at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-08-07.

Sponsored by Yale University · Not applicable, Interventional, and Treatment

Why this study was terminated
Investigator Moved Institutions
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to compare the clinical and radiographic outcomes of full endoscopic lumbar discectomy versus open lumbar decompression for the treatment of lumbar herniated discs in which the patient's leg pain is greater than back pain.

Read the detailed description

The study will be performed utilizing a prospective multi-center randomized model. Approximately 7 centers will be included in the study as listed above. Patients will be informed of clinical trial and asked if they would like to participate. Patients are informed that participation is optional. Patients may withdraw from study any time prior to or after surgery. Patients will be randomized 2:1 ratio endoscopic:open surgery. Both the endoscopic and open surgical techniques are utilized in standard of care. If a subject requires an open surgery approach (based on the surgeons assessment at the time of surgery pre or post incision) after they are randomized to the endoscopic arm, they will be switched to the open arm and included in the open crossover arm of the study.

Study procedures will occur at the following time points; Pre-op, 6 wk, 3 mon, 6 mon, 1 yr and 2 yr follow-up.Subjects will complete questionnaires that assess pain level and location, functional capacity, work and health status, medication usage and duration of symptoms.

02

Conditions studied

  • Lumbar Disc Herniation
03

In context

Intervertebral Disc Displacement

478 studies on the registry are indexed under Intervertebral Disc Displacement; 104 are open to participants now.

This study's planned enrollment of 200 is above the median of 63 across 344 interventional studies indexed under Intervertebral Disc Displacement.

Browse Intervertebral Disc Displacement studies →

Lead sponsor

Yale University is the lead sponsor of 1,724 studies on the registry; 298 are open to participants now.

Of its 210 completed or terminated interventional studies of FDA-regulated products, 126 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Patient equal to or greater than 18 years old.
  2. Patients with single level para-central herniated discs from L1-S1.
  3. VAS (Visual Analog Scale) leg > 40 mm.
  4. Leg pain must be greater than back pain.
  5. Minimum 6 weeks conservative treatment unless motor strength U\< U4/5 and or deteriorating neurologic function.

Exclusion criteria

Exclusion Criteria:

  1. Lateral/subarticular, far lateral disc herniations
  2. Multi-focal (multi modal) disc herniations
  3. Symptomatic multiple level disc herniations
  4. Active infection either spinal or otherwise
  5. Prior history of lumbar spinal infection at any level
  6. Spinal tumor in lumbar region
  7. Dynamic (any grade) or fixed spondylolisthesis more than 3mm
  8. Disc extrusion that is more superior than most inferior aspect of superior pedicle above index disc level
  9. Disc extrusion that is more inferior than the middle aspect of inferior pedicle below the index disc level
  10. Presence of unilateral or bilateral pars inter articularis defects (spondylolysis)
  11. Disc herniation which is significantly calcified
  12. Contra-lateral leg pain U>40 mm
  13. History of peripheral diabetic neuropathy
  14. Significant central stenosis with history of neurogenic claudication
  15. Pregnancy
  16. Facet cyst on symptomatic side
  17. Cauda Equina syndrome past or present
  18. Patients cannot have had prior lumbar surgery including IDET (Intradiscal Electrothermal Therapy) or other percutaneous surgical procedures.
  19. Significant vascular claudication
  20. History of radiation to the spinal column
  21. History of malignancy of any type within 2 years of consideration of enrollment
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Active comparator
    Endoscopic Discectomy

    Randomized to Endoscopic Discectomy Lumbar discectomy Endoscopic Intervention type is lumbar endoscopic surgery- no device or drug

    Procedure: Lumbar discectomy Endoscopic

  • Active comparator
    Open Discectomy

    Randomized to Open Discectomy Lumbar discectomy Open Intervention type is lumbar open surgery- no device or drug

    Procedure: Lumbar discectomy Open

  • Other
    Open Discectomy-Cross Over Arm

    Randomized to Endoscopic Discectomy Cross over to lumbar discectomy open based on surgeons assessment pre or post incision Intervention type is lumbar open surgery- no device or drug

    Procedure: Lumbar discectomy Open

Interventions

  • ProcedureLumbar discectomy Open

    Open Discectomy

    Also known as: Intervention type is lumbar Open surgery- no device or drug

  • ProcedureLumbar discectomy Endoscopic

    Endoscopic Discectomy

    Also known as: (Intervention type is lumbar endoscopic surgery- no device or drug

06

What researchers measure

Primary outcomes

  1. Leg pain as assessed by VAS score

    Time frame: 2 years

07

Study locations

1 site
  • Yale New Haven Hospital
    New Haven, Connecticut 06520, United States
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 7, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02441959
Lead sponsor
Yale University
Collaborators
University of New Mexico, University of Washington, Desert Institute for Spine Care, Trinity Spine Center, Baton Rouge Ortho Clinic, Orthopedic and Neurological Consultants, Inc.
Responsible party
Sponsor
First posted
May 12, 2015
Start date
Jun 2015
Primary completion
Jul 2018
Completion
Jul 2018
Last update
Aug 7, 2018

Study contacts

James J Yue, MD
principal investigator · Yale University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion